| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) | 
|---|
| 09/06/1991 | CA2077665A1 Chymotrypsin-like proteases and their inhibitors | 
| 09/06/1991 | CA2037238A1 Method for treating pneumocystis pneumonia | 
| 09/05/1991 | WO1991013092A1 Vasoactive vasotocin derivatives | 
| 09/05/1991 | WO1991012812A1 Inhibitors of catalytic antibodies | 
| 09/04/1991 | EP0444898A1 Cyclic hexapeptide oxytocin antagonists | 
| 09/04/1991 | EP0444897A1 Novel immunosuppressive cyclosporin analogs with modified amino acids at position-8 | 
| 09/04/1991 | EP0444605A2 Angiotensin converting enzyme inhibitor, method for preparing it, composition containing the same and use thereof | 
| 09/03/1991 | US5045531 Administering amphiphilic polypeptide as wound healing agent | 
| 08/29/1991 | WO1991013088A1 Terminally blocked antiviral peptides | 
| 08/29/1991 | WO1991013081A1 Physiologically active substance well capable of permeating biomembrane | 
| 08/29/1991 | CA2077088A1 Terminally blocked antiviral peptides | 
| 08/29/1991 | CA2076849A1 Physiologically active substance well capable of permeating biomembrane | 
| 08/29/1991 | CA2037199A1 Inhibitors of catalytic antibodies | 
| 08/28/1991 | EP0443719A1 Novel R106 compounds | 
| 08/28/1991 | EP0443598A2 Peptides inhibiting the blood coagulation, their process of preparation and their use | 
| 08/28/1991 | EP0443532A2 Temporary minimal protection synthesis of LH-RH analogs | 
| 08/28/1991 | EP0443429A1 Stabilized sulfonate, sulfate, phosphonate and phosphate derivatives of hirudin | 
| 08/28/1991 | EP0443404A1 Peptide fragments and analogs of thrombospondin | 
| 08/28/1991 | EP0442926A1 Polypeptides | 
| 08/28/1991 | CA2036973A1 Cyclic hexapeptide oxytocin antagonists | 
| 08/28/1991 | CA2036963A1 Immunosuppressive cyclosporin analogs with modified amino acids at position-8 | 
| 08/27/1991 | CA1288195C Gnrh antagonists ix | 
| 08/24/1991 | WO1991012815A1 COMPOSITIONS AND METHODS FOR TREATING INFECTIONS CAUSED BY ORGANISMS SENSITIVE TO β-LACTAM ANTIBIOTICS | 
| 08/24/1991 | CA2076529A1 Compositions and methods for treating infections caused by organisms sensitive to beta-lactam antibiotics | 
| 08/23/1991 | CA2036815A1 Peptides which inhibit blood coagulation, processes for the preparation thereof and the use thereof | 
| 08/23/1991 | CA2036093A1 Peptide fragments and analogs of thrombospondin | 
| 08/22/1991 | WO1991012269A1 Immunologically active peptides or polypeptides from the parvovirus b19 | 
| 08/22/1991 | WO1991012015A1 Biologically active amphiphilic peptides and method of inhibiting growth of target cells, virus or virally-infected cell | 
| 08/21/1991 | EP0442538A1 High purified protein, production and use thereof | 
| 08/21/1991 | EP0442394A2 Synthetic peptides specific for the detection of antibodies to HCV, diagnosis of HCV infection and prevention thereof as vaccines | 
| 08/21/1991 | EP0441882A1 Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides | 
| 08/21/1991 | EP0441871A1 A sheet feeding apparatus | 
| 08/21/1991 | EP0441832A1 Composition and treatment with biologically active peptides and certain anions. | 
| 08/20/1991 | US5041644 Bactericides | 
| 08/20/1991 | US5041533 Hinge peptide, a process for its manufacture, and its use for the manufacture of synthetic immunogens | 
| 08/14/1991 | DE4003881A1 Human antibody library | 
| 08/14/1991 | DE4003880A1 Synthetic human antibody library | 
| 08/14/1991 | DE4003826A1 Immunologisch aktive peptide des parvovirus b19 Immunologically active peptide of parvovirus b19 | 
| 08/13/1991 | US5039792 Allatostatins which inhibit insect juvenile hormone biosynthesis | 
| 08/13/1991 | US5039789 Antibacterial agents | 
| 08/13/1991 | US5039662 Pentapeptide containing tyrosine, isoleucine, glycine serine, and arginine | 
| 08/13/1991 | CA2036007A1 Cytotoxic n, n'-bis (succinyl-peptide)-derivatives of 1,4-bis (aminoalkyl)-5,8-dihydroxyanthraquinones and antibody conjugates thereof | 
| 08/10/1991 | WO1991012267A1 Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof | 
| 08/10/1991 | CA2075705A1 Anti-oxidative and anti-inflammatory metal:peptide complexes and uses thereof | 
| 08/09/1991 | CA2035959A1 Peptide compositions and uses therefor | 
| 08/08/1991 | WO1991011457A1 Glp-1 analogs useful for diabetes treatment | 
| 08/08/1991 | WO1991011456A1 EXTRACELLULAR SEGMENTS OF HUMAN ε IMMUNOGLOBULIN ANCHORING PEPTIDES AND ANTIBODIES SPECIFIC THEREFOR | 
| 08/08/1991 | DE4002898A1 Human antibody library | 
| 08/08/1991 | DE4002897A1 Synthetic human antibody library | 
| 08/07/1991 | WO1991012013A1 CYCLIC GnRH ANTAGONISTS | 
| 08/07/1991 | EP0440147A2 Preparation and use of a human antibody gene bank (human antibody libraries) | 
| 08/07/1991 | EP0440146A2 Preparation and use of synthetic human antibody gene bank (synthetic human antibody libraries) | 
| 08/07/1991 | CA2073766A1 Cyclic gnrh antagonists | 
| 08/06/1991 | US5037957 Cysteine proteinase inhibitor | 
| 08/06/1991 | CA1287447C Peptides useful in vaccination against enteroviruses | 
| 07/31/1991 | EP0439174A2 Inhibition of gut endothelium ion-secretion by peptide derivatives | 
| 07/31/1991 | EP0439077A2 Synthetic peptide compositions with immunoreactivities to antibodies to HTLV | 
| 07/31/1991 | EP0438873A1 Inhibitor of ribonucleotide reductase of herpes viruses | 
| 07/31/1991 | EP0438813A1 A novel antibiotic, Deoxymulundocandin, a process for its production and its use as medicament | 
| 07/31/1991 | EP0438566A1 Therapeutic peptides. | 
| 07/31/1991 | EP0438519A1 Therapeutic peptides | 
| 07/30/1991 | CA1286989C Immunoamplifiers and related compositions | 
| 07/25/1991 | WO1991010442A1 Hiv protease inhibitors | 
| 07/25/1991 | DE4001236A1 New oligopeptide(s) contg. 2-amino-2-methyl propionic acid residue - are antiviral agents for human or veterinary therapy including treatment of AIDS and ARC | 
| 07/24/1991 | EP0437729A2 New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses | 
| 07/24/1991 | EP0437604A1 Recombinant poxvirus and streptococcal m protein vaccine | 
| 07/24/1991 | EP0437556A1 Substitution analogues of magainin peptides. | 
| 07/24/1991 | CA2008438A1 Peptides inhibiting the maturation of t-lymphocytes and the activity of macrophages, pharmaceutical compositions containing them and process for preparing same | 
| 07/23/1991 | US5034510 Polypeptides as antibacterial agents | 
| 07/23/1991 | CA1286847C Peptide derivatives analogous to pepstatin, which inhibit renin and acid proteases | 
| 07/23/1991 | CA1286846C Peptide derivatives which inhibit renin and acid proteases | 
| 07/23/1991 | CA1286607C Cyclic and bridged cyclic somatostatin analogs useful as analgesic agents | 
| 07/19/1991 | CA2034385A1 Vector to produce biologically important peptides | 
| 07/17/1991 | EP0436634A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids | 
| 07/16/1991 | US5032271 Desalination, polypeptides | 
| 07/11/1991 | WO1991009613A1 Synthetic peptides as modulators of functional responses of intact cells | 
| 07/10/1991 | WO1991010681A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues | 
| 07/10/1991 | EP0436189A1 Endothelin atagonistic cyclic pentapeptides | 
| 07/10/1991 | EP0435877A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response | 
| 07/10/1991 | CN1013120B Improved process for producing a-21978c derivative | 
| 07/10/1991 | CA2072253A1 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues | 
| 07/09/1991 | US5030718 Against htlc, in pure form | 
| 07/09/1991 | US5030714 Isolated or synthetic peptide; diagnosis of aids | 
| 07/09/1991 | US5030449 Synthetic vaccine against AIDS virus | 
| 07/05/1991 | WO1991009614A1 GPIbα FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS | 
| 07/05/1991 | CA2072753A1 Gpi.beta.o fragments and recombinant dna expression vectors | 
| 07/03/1991 | EP0435503A1 Improvements in or relating to gylcopeptide derivatives | 
| 07/03/1991 | EP0434979A1 Peptide derivatives useful as antagonists of bombesin and gastrin-releasing peptide | 
| 07/03/1991 | EP0434722A1 New pentapeptide and a process for the preparation thereof | 
| 07/03/1991 | EP0434718A1 Peptide compounds | 
| 07/02/1991 | US5028692 Gastrin releasing peptide antagonist | 
| 07/02/1991 | US5028590 Derivatives of A54145 cyclic peptides | 
| 07/02/1991 | US5028586 Eliminating some or all of the acid containing side chains by esterification or replacement of glutamic acid residues with glutamine, prolonged action | 
| 06/27/1991 | WO1991009059A1 Antibody antagonists of human interleukin-4 | 
| 06/27/1991 | WO1991009055A1 Acylated bradykinin antagonists and uses therefor | 
| 06/27/1991 | WO1991008758A1 Wound treatment employing biologically active peptides | 
| 06/26/1991 | EP0433345A1 Peptide synthesis method and solid support for use in the method. | 
| 06/26/1991 | EP0433276A1 Growth hormone related peptide | 
| 06/26/1991 | CN1052483A Improvements in or relating to glycopeptide derivatives | 
| 06/25/1991 | US5026703 Peptide oxytocin antagonists |